Autori: Agosto C

Filtra

Data

Prevalence of Duchenne muscular dystrophy in Italy: a nationwide survey

Type I spinal muscular atrophy and disease modifying treatments: a nationwide study in children born since 2016

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in na‹ve patients with spinal muscular atrophy and following switch from other therapies

Type I spinal muscular atrophy patients treated with nusinersen: 4-year follow-up of motor, respiratory and bulbar function

Prevalence of Spinal Muscular Atrophy in the Era of Disease-Modifying Therapies: An Italian Nationwide Survey

Torna in alto